Saturday, November 14, 2009

Last Update from Acell (MicroMatrix-Donor site repair)

Patient History:
Patient presented with donor site scar from previous hair transplant restoration procedure. MatriStem
MicroMatrix applied to donor site during transplant procedure of plucked temple hair. Donor site remodeled within three months.
MatriStem MicroMatrix is intended for the management of wounds including: partial and full-thickness wounds,
pressure ulcers, venous ulcers, diabetic ulcers, chronic vascular ulcers, tunneled/undermined wounds, surgical
wounds (donor sites/grafts, post-Moh’s surgery, post-laser surgery, podiatric, wound dehiscence), trauma wounds
(abrasions, lacerations, second-degree burns, and skin tears), and draining wounds.

My question is: what means "remodeled". Means a new born of skin, without new hairs, or a new born of new skin with a follicular neogenesis of the donor site?
I will contact acell asap to make this question, and post here the answer.

Friday, November 13, 2009


"BioNuesis is the first all-human soluble extracellular matrix, developed as a culturing kit for stem cell growth.
Our manufacturing process and QC testing provide uniform ECM.
Human Feeder Layer ECM
BioNuesis is delivered in a tube and is ready to use, no messy gels.
No Tumor Growth Factors
Laminin, Fibronectin & Collagen 4
BioNuesis contains only soluble, natural human ECM.
All Human
BioNuesis contains Extracellular Matrix from human fibroblasts

A product of Histogen, Inc., BioNuesis is an effective, easy-to-use product that utilizes a unique "Dilute & Shoot" process. It coats in one hour, or overnight for best results."


One of the most promising society is "Aderans". From his site, on the page about clinical updates, they declared this:
"We are conducting a Phase 2 clinical study to further evaluate the ability of our unique cell treatment process to elicit hair growth in men and women with hair loss. Based on the outcomes of our recent Phase 1 study conducted in the United Kingdom, Phase 2 will continue our research into the benefits of our process on pattern hair loss, known as androgenetic alopecia. The treatment is not intended for those with a different underlying condition. More information on our outcomes will be made available as our studies conclude. If you are interested in participating in the Phase 2 study, please select a city for further information."
Still working on...

Hi All!

My name is Marc, i'm a journalist interested in science and research (losing hairs like you all, unfortunately). In this years i've followed closely a lot of forums and sites, about hair technologies, tryng to be always updated about all the news from this specific science sector. With my experience i hope to give you all a different, simple (without confusion, off topic discussions, useless posts and other boring things of the most viewed sites) always updated space to speak ONLY about this specific argument, without interferences or other different discussions about hairs. I really believe in the research and in the future, and i'm very sure that cell research will give us a definitive solution for our problem.

With this blog, i want to find and publish only the interesting and serious news/studies about hairs-research, to give you a competent blog where read and know all about it. I hope you will appreciate this work and try to partecipate actively to make this blog always better!